IndiaRF announces ₹992 crore investment in Panacea Biotec

In similar vein, Panacea Biotec MD Rajesh Jain said: “We look forward to leveraging their proven global expertise in restructuring and turnarounds, and are certain that our combined efforts will now help accelerate our ambitious growth and profitability targets.” Brescon & Allied Partners LLP were the exclusive advisors to the company on this transaction, advising on the one-time settlement with the banks and raising funding to back the revival plan, the statement said.